Q2 2022 SMS Pharmaceuticals Ltd Earnings Call Transcript
By our financial highlights. So SMS Pharma was established in 1990. SMS pharma is a global API intermediate player with strong research and manufacturing teams supported by state of the art manufacturing facilities. It has capabilities for a wide range of APIs intermediates and has handled varied process reactions and reactor volumes up to 3,000 KL.
Undertaking contract manufacturing of API and advanced and basic intermediates offering a competitive advantage to the clients, especially in the latest stage life cycle of the products. With a demonstrated manufacturing excellence over last two decades in broad portfolio of therapeutic segment, the company has become a trusted partner to a customer base in over 70 countries, including clientele in top 20 pharmaceutical companies.
The API segment is focused on providing products across a diverse range of therapies such as ARVs, antivirals, antiulcer, antimigraine, antiepileptic, anti-erectile dysfunction. This strategy is to focus on equality market leadership and backward integration,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |